Burkina Faso: FASO-PHARMA, a strategic step towards pharmaceutical sovereignty thanks to the commitment of Captain Ibrahim Traoré
In Burkina Faso, structural development initiatives are multiplying under the leadership of President Captain Ibrahim Traoré. In support of healthcare progress, the government has taken a new decisive step. During the Council of Ministers meeting held on Wednesday, June 4, the state authorized the Burkinabe National Lottery (LONAB) to invest 1.4 billion CFA francs in the share capital of the company FASO-PHARMA, representing 28% of the total capital—an action with significant economic and strategic implications.
This investment by LONAB in the management company of the integrated pharmaceutical technopole of Kokologho is no coincidence. It reflects a clear political will to build a strong national pharmaceutical industry capable of meeting the health needs of Burkinabe citizens and reducing reliance on imports. Captain Traoré, true to his vision of rebuilding the country on the foundations of sovereignty and resilience, once again demonstrates that well-directed national resources can become powerful levers for sustainable development.
Through this equity participation, LONAB is taking on an active role in the real economy, going beyond its traditional role of managing games of chance. It is now becoming a development actor, using its surpluses to boost a vital sector: pharmaceuticals. This financial support will accelerate the operational launch of FASO-PHARMA—a major project for public health, the creation of skilled jobs, and the development of local industrial expertise.
Under the leadership of Captain Ibrahim Traoré, Burkina Faso is clearly paving the way toward health independence. A bold, strategic choice that brings hope for both present and future generations.
